News

Filter

Current filters:

AllerganPharmaceutical

1 to 9 of 81 results

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Valeant admits disappointment at loss of takeover target Allergan to Actavis

Valeant admits disappointment at loss of takeover target Allergan to Actavis

19-11-2014

Canadian drugmaker Valeant International has admitted that the loss of hostile takeover target Allergan…

ActavisAllerganCanadaMergers & AcquisitionsPharmaceuticalValeant

Allergan agrees to $66 billion acquisition by Actavis

Allergan agrees to $66 billion acquisition by Actavis

17-11-2014

Confirming what were becoming ever stronger rumors over the weekend, Ireland-headquartered Actavis this…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSAValeant Pharmaceuticals International

Pershing Square chief urges Allergan not to favor Actavis over Valeant in negotiations

Pershing Square chief urges Allergan not to favor Actavis over Valeant in negotiations

10-11-2014

The chief executive of the capital management company assisting Valeant Pharmaceuticals in its attempts…

ActavisAllerganBusiness FinanceBusiness FinanceCanadaPershing Square Capital ManagementPharmaceuticalUSAValeant

Allergan is reportedly in takeover talks with Actavis

Allergan is reportedly in takeover talks with Actavis

07-11-2014

Botox maker Allergan is reportedly in merger talks with Ireland-headquartered generics major Actavis,…

ActavisAllerganMergers & AcquisitionsPharmaceuticalUSA

Allergan posts strong results which provoke reaction from potential suitor Valeant

Allergan posts strong results which provoke reaction from potential suitor Valeant

27-10-2014

Botox maker Allergan has reported strong quarterly results amid an ongoing buyout dispute with Quebecois…

AllerganBotoxBusiness FinancePharmaceuticalUSAValeant

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

Allergan says Pershing’s additional requests for meeting is not “meaningful development”

15-09-2014

Hostile takeover target Allergan has said that value is what “really matters” in response to Pershing…

AllerganCanadaFinancialLegalPharmaceuticalUSAValeant Pharmaceuticals International

Allergan’s Ozurdex approved for DME in Europe

Allergan’s Ozurdex approved for DME in Europe

02-09-2014

Allergan revealed today that the European Commission has extended the marketing authorization for Ozurdex…

AllerganEuropeOphthalmicsOzurdexPharmaceuticalRegulation

1 to 9 of 81 results

COMPANY SPOTLIGHT

Menarini

Back to top